Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
ROS Therapeutics ApS
APS
Active
CVR 39507501
Veddelev Engvej 6, 4000
Roskilde
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2018 · 8 years old
1 employees
Overvåg
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
ROS Therapeutics ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
-0M
-1M
-1M
-1M
-2M
2020
-5M
2021
-3M
2022
-1M
2023
-1M
2024
EBITDA
DKK millions
0M
-2M
-3M
-5M
-6M
-2M
2020
-5M
-150%
2021
-4M
+20%
2022
-1M
+75%
2023
-1M
0%
2024
Income statement
DKK thousands
Item
2020
2021
2022
2023
2024
Gross profit
-2.038
-4.763
-3.096
-678
-584
Staff expenses
-151
-605
-616
-13
-8
EBITDA
-2.188
-5.368
-3.712
-690
-592
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-2.188
-5.368
-3.712
-690
-592
Net financials
-115
-355
-372
-538
-737
Profit before tax
-2.303
-5.723
-4.085
-1.228
-1.329
Tax
-403
-1.341
-734
-76
-14
Net profit
-1.900
-4.381
-3.350
-1.152
-1.315
Balance sheet
DKK thousands
Item
2020
2021
2022
2023
2024
Total assets
10.176
6.287
3.373
1.907
1.335
Equity
3.623
-758
-4.108
-5.261
-6.576
Long-term debt
5.915
6.132
6.432
6.941
7.628
Short-term debt
638
913
1.049
227
282
Total debt
6.553
7.045
7.481
7.168
7.911
Financial ratios
5-year trend
EBITDA-margin (af bruttofortjeneste)
-59175100.0%
This company
2020
2024
Soliditetsgrad
-492.5%
This company
38.2%
Market median
-1389% vs market
2020
2024
Egenkapitalforrentning
-131491500.0%
This company
18.4%
Market median
-714627817% vs market
2020
2024
Nettoresultatgrad (af bruttofortjeneste)
-131491500.0%
This company
2020
2024
Aktivomsætning (af bruttofortjeneste)
-0.44×
This company
2020
2024
Gæld/egenkapital
1.20×
This company
0.62×
Market median
-94% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
More on ROS Therapeutics ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
